Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. (Q37990779)

26 August 2017

title

Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. (English)

1 reference

26 August 2017

0 references

0 references

Vera Pravica

1 reference

26 August 2017

Dusan Popadic

1 reference

26 August 2017

Emina Savic

1 reference

26 August 2017

Milos Markovic

1 reference

26 August 2017

Jelena Drulovic

1 reference

26 August 2017

Marija Mostarica-Stojkovic

1 reference

26 August 2017

publication date

1 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

issue

1-2

1 reference

26 August 2017

page(s)

42-52

1 reference

The epidemiology of multiple sclerosis in Europe.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Translation towards personalized medicine in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Pathogenic CD8(+) T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Disturbed regulatory T cell homeostasis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

The contribution of gammadelta T cells to the pathogenesis of EAE and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Lack of association between antimyelin antibodies and progression to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Multiple sclerosis and HLA class II susceptibility and resistance genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

The CTLA-4 gene is associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Association studies for asthma and atopic diseases: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Multiple sclerosis susceptibility alleles in African Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Multiple Sclerosis Genetics 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

TNF-376A marks susceptibility to MS in the Spanish population: A replication study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

A novel polymorphism of the human CD40 receptor with enhanced function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Managing MS in a changing treatment landscape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Interferon-beta mechanisms of action in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Glypican-1 and alpha4(V) collagen are required for Schwann cell myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

When sugars guide axons: insights from heparan sulphate proteoglycan mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Heparan sulfate proteoglycans and the emergence of neuronal connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

OAS1: a multiple sclerosis susceptibility gene that influences disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8273-Y

10.1007/S12026-012-8273-Y

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference